CYTO Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CYTO shares is N/A, representing N/A of the company's common stock.

SUSQUEHANNA INTERNATIONAL GROUP, LLP, in the last quarter, reduced its stake in CYTO by -100% restricting it's holding to 0 shares of worth nearly -. TOWER RESEARCH CAPITAL LLC (TRC) also lessened -100% of the CYTO shares from its portfolio, reducing its holding to 0 shares of worth -. CUTLER GROUP LLC / CA also shunned CYTO shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, SIMPLEX TRADING, LLC increased its stake in CYTO by 100% in the last quarter. The institutional holder raised its holding to 7.55 thousand shares having worth more than $2.00K. VIRTU FINANCIAL LLC also added 866.82% more shares of CYTO to its portfolio, raising its holding to 124.79 thousand shares of worth $36.00K. MORGAN STANLEY also increased its CYTO shares holding by 123.31% which brought its holding to 58.73 thousand shares worth $17.00K.

The insider with the most stakes in CYTO is SCHNITTKER CHRISTOPHER P , Sr. Vice President and CFO at the company. Additionally, CYTO stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own N/A percent of Altamira Therapeutics Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which CYTO insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

There have been 0 transaction(s) during the past 6-months in which Altamira Therapeutics Ltd. insiders have bought stock, totalling 0 shares

Around 0 Altamira Therapeutics Ltd. shares are held by insiders, which represents about N/A of CYTO stock.

CYTO Sr. Vice President and CFO, SCHNITTKER CHRISTOPHER P holds the largest portfolio of the company's shares. CYTO shares owned by SCHNITTKER total nearly 1.2 thousand.

SIMPLEX TRADING, LLC is the largest institutional owner in CYTO which holds 7.55 thousand shares worth $2.00K or 0.06% of the total CYTO shares outstanding followed by WELLS FARGO & COMPANY/MN with ownership of 500 shares representing 0% of the CYTO ownership. ADVISOR GROUP HOLDINGS, INC. is the third largest stakeholder with 310 shares or 0% of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CYTO is concerned, it is a stock which is not optionable.

Number of CYTO shares short is 50.63K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 3.78M shares of CYTO are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CYTO has 2.65M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CYTO is 0.52.